scholarly journals Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

2015 ◽  
Vol 36 (30) ◽  
pp. 2011-2017 ◽  
Author(s):  
Philippe Menasché ◽  
Valérie Vanneaux ◽  
Albert Hagège ◽  
Alain Bel ◽  
Bernard Cholley ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Case Report ◽  
Human Embryonic Stem Cell ◽  
Clinical Case ◽  
Embryonic Stem ◽  
Severe Heart Failure ◽  
Heart Failure Treatment ◽  
Cardiac Progenitors ◽  
Failure Treatment

Elderly patients with systolic dysfunction and severe heart failure benefit from an aggressive heart failure treatment program

1999 ◽  
Vol 5 (3) ◽  
pp. 79
Author(s):  
John S. Golden ◽  
Catherine Chelimsky-Fallick ◽  
Donna J. Mateski ◽  
Colleen M. Healey ◽  
Sharon R. Josephson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Elderly Patients ◽  
Treatment Program ◽  
Systolic Dysfunction ◽  
Severe Heart Failure ◽  
Heart Failure Treatment ◽  
Failure Treatment

scholarly journals Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Michael Barrie ◽  
Lucas McKnight ◽  
Pallavi Solanki
Keyword(s):  
Heart Failure ◽  
Coronary Arteries ◽  
Immunosuppressive Agents ◽  
Viral Myocarditis ◽  
Severe Heart Failure ◽  
Steroid Treatment ◽  
Fulminant Myocarditis ◽  
Unknown Etiology ◽  
Heart Failure Treatment ◽  
Failure Treatment

We report a case of a 59-year-old woman who presented with worsening dyspnea which rapidly progressed to severe heart failure. Coronary arteries showed no obstruction. Supportive measures stabilized the patient’s hemodynamics. Initially intravenous solumedrol was given, but when the patient’s condition continued to deteriorate, intravenous immunoglobulin (IVIG) was added to the treatment regimen and her condition improved. Studies show no benefit to using immunosuppressive agents in viral myocarditis, but benefits have been demonstrated in other etiologies. Patients presenting with acute fulminant myocarditis with unknown etiology that continue to deteriorate with aggressive heart failure treatment may benefit from steroids and IVIG.

scholarly journals Adjuvant pericardial sac restraining in heart failure treatment. A medical hypothesis illustrated by a case report.

2015 ◽  
Vol 31 (1) ◽  
Author(s):  
Paulo Roberto Barbosa Evora ◽  
Minna Moreira D. Romano ◽  
Luis Gustavo Gali ◽  
André Schmidt ◽  
Alfredo José Rodrigues
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Heart Failure Treatment ◽  
Failure Treatment ◽  
Medical Hypothesis

scholarly journals Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature

2021 ◽  
Vol 29 ◽  
pp. e00277
Author(s):  
Giuseppe Caruso ◽  
Annalisa Scopelliti ◽  
Sara Scaramuzzino ◽  
Giuseppina Perrone ◽  
Paola Galoppi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Peripartum Cardiomyopathy ◽  
Review Of The Literature ◽  
Heart Failure Treatment ◽  
Failure Treatment

scholarly journals Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

2014 ◽  
Vol 36 (12) ◽  
pp. 743-750 ◽  
Author(s):  
Philippe Menasché ◽  
Valérie Vanneaux ◽  
Jean-Roch Fabreguettes ◽  
Alain Bel ◽  
Lucie Tosca ◽  
...  
Keyword(s):  
Stem Cell ◽  
Embryonic Stem Cell ◽  
Human Embryonic Stem Cell ◽  
Embryonic Stem ◽  
Clinical Use ◽  
Cardiac Progenitors
Sign in / Sign up

Export Citation Format

Share Document